Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis.

Wallace DJ, Gavin IM, Karpenko O, Barkhordar F, Gillis BS.

Rheumatol Int. 2015 Jun;35(6):991-6. doi: 10.1007/s00296-014-3172-2. Epub 2014 Nov 7.

3.

IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.

Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y, Yu T, Chen B, Zhang J, Ding L, Du J, Huang Z.

J Transl Med. 2014 Mar 16;12:69. doi: 10.1186/1479-5876-12-69.

4.

Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.

Cai Z, Wong CK, Kam NW, Dong J, Jiao D, Chu M, Lam CW, Tam LS.

Lupus. 2015 Oct;24(12):1257-66. doi: 10.1177/0961203315585815. Epub 2015 May 11.

PMID:
25966926
6.

Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB.

J Rheumatol. 2011 Jun;38(6):1113-22. doi: 10.3899/jrheum.100594. Epub 2011 Feb 1.

PMID:
21285161
7.

Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus.

Scuderi F, Convertino R, Molino N, Provenzano C, Marino M, Zoli A, Bartoccioni E.

Autoimmunity. 2003 Mar;36(2):71-7.

PMID:
12820688
8.

Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.

Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA.

Cytokine. 2015 Apr;72(2):146-53. doi: 10.1016/j.cyto.2014.12.027. Epub 2015 Jan 31.

PMID:
25647269
9.

Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE).

Monsiváis-Urenda A, Niño-Moreno P, Abud-Mendoza C, Baranda L, Layseca-Espinosa E, López-Botet M, González-Amaro R.

J Autoimmun. 2007 Sep-Nov;29(2-3):97-105. Epub 2007 Jun 29.

PMID:
17601702
10.

Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients.

Silva JC, Mariz HA, Rocha LF Jr, Oliveira PS, Dantas AT, Duarte AL, Pitta Ida R, Galdino SL, Pitta MG.

Clinics (Sao Paulo). 2013 Jun;68(6):766-71. doi: 10.6061/clinics/2013(06)07.

11.

Chronic widespread pain in the spectrum of rheumatological diseases.

Atzeni F, Cazzola M, Benucci M, Di Franco M, Salaffi F, Sarzi-Puttini P.

Best Pract Res Clin Rheumatol. 2011 Apr;25(2):165-71. doi: 10.1016/j.berh.2010.01.011. Review.

PMID:
22094193
12.

Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.

Higgs BW, Zhu W, Richman L, Fiorentino DF, Greenberg SA, Jallal B, Yao Y.

Int J Rheum Dis. 2012 Feb;15(1):25-35. doi: 10.1111/j.1756-185X.2011.01654.x. Epub 2011 Aug 31.

PMID:
22324944
13.

Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis.

Shah D, Wanchu A, Bhatnagar A.

Immunobiology. 2011 Sep;216(9):1010-7. doi: 10.1016/j.imbio.2011.04.001. Epub 2011 Apr 13.

PMID:
21601309
14.

The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.

Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH.

Eur J Clin Invest. 2007 Dec;37(12):987-96.

PMID:
18036033
15.

T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients.

Muñoz-Valle JF, Vázquez-Del Mercado M, García-Iglesias T, Orozco-Barocio G, Bernard-Medina G, Martínez-Bonilla G, Bastidas-Ramírez BE, Navarro AD, Bueno M, Martínez-López E, Best-Aguilera CR, Kamachi M, Armendáriz-Borunda J.

Clin Exp Immunol. 2003 Feb;131(2):377-84.

16.
17.

Novel multiplex technology for diagnostic characterization of rheumatoid arthritis.

Chandra PE, Sokolove J, Hipp BG, Lindstrom TM, Elder JT, Reveille JD, Eberl H, Klause U, Robinson WH.

Arthritis Res Ther. 2011 Jun 24;13(3):R102. doi: 10.1186/ar3383.

18.

The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner.

Deane KD, O'Donnell CI, Hueber W, Majka DS, Lazar AA, Derber LA, Gilliland WR, Edison JD, Norris JM, Robinson WH, Holers VM.

Arthritis Rheum. 2010 Nov;62(11):3161-72. doi: 10.1002/art.27638.

19.

Heterogeneity of the cytokinome in undifferentiated arthritis progressing to rheumatoid arthritis and its change in the course of therapy. Move toward personalized medicine.

Brzustewicz E, Bzoma I, Daca A, Szarecka M, Bykowska MS, Witkowski JM, Bryl E.

Cytokine. 2017 Sep;97:1-13. doi: 10.1016/j.cyto.2017.05.012. Epub 2017 May 25.

PMID:
28551592
20.

Clinical utility of red blood cell distribution width in inflammatory and non-inflammatory joint diseases.

Horta-Baas G, Romero-Figueroa MDS.

Int J Rheum Dis. 2019 Jan;22(1):47-54. doi: 10.1111/1756-185X.13332. Epub 2018 Aug 30.

PMID:
30168259

Supplemental Content

Support Center